Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Lupus Nephritis
NCT00447265Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2008
- Primary completion
- Mar 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in lupus nephritis (LN), sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2008; status: terminated.
02
Drugs
etanercept
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00447265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447265.